Jump to main content
Jump to site search

Issue 94, 2012
Previous Article Next Article

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Author affiliations

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

Graphical abstract: Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 04 Sep 2012, accepted on 12 Oct 2012 and first published on 18 Oct 2012


Article type: Communication
DOI: 10.1039/C2CC36456E
Citation: Chem. Commun., 2012,48, 11567-11569
  •   Request permissions

    Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

    G. Fu, W. Liu, S. Feng and X. Yue, Chem. Commun., 2012, 48, 11567
    DOI: 10.1039/C2CC36456E

Search articles by author

Spotlight

Advertisements